Geriatric Depression Rating Scale (GDS)

Abstract

The Geriatric Depression Scale (GDS), originally conceptualized and validated by Jerome A. Yesavage, T. L. Brink, and colleagues in 1982–1983, represents one of the most widely deployed and rigorously examined clinical psychometric screening instruments designed specifically for older adult populations. Developed in response to profound diagnostic challenges in geriatric psychiatry—namely, the pervasive confounding of somatic complaints arising from physical illness, medication side effects, and normative biological aging with neurovegetative depressive symptoms—the GDS deliberately de-emphasizes somatic indicators in favor of cognitive, affective, behavioral, and motivational markers of late-life affective disturbance. The original long form (GDS-LF) comprises 30 items presented in a simple, forced-choice dichotomous (Yes/No) response format, specifically chosen to reduce cognitive load, minimize fatigue, and accommodate varying levels of visual acuity and executive function. Subsequently, a widely utilized 15-item short form (GDS-SF) was extracted by Sheikh and Yesavage in 1986. Extensive empirical investigations demonstrate that the GDS exhibits exceptional psychometric properties across diverse institutional and community settings, including acute inpatient medical units, residential nursing facilities, outpatient clinics, and community-dwelling epidemiologic cohorts. The instrument possesses high internal consistency (Cronbach’s alpha ranging from .92 to .94 for the 30-item version; split-half reliability coefficient of .94) and robust test-retest stability (coefficients of .85 at one-week and one-month intervals). Criterion validity against structured clinical diagnostic standards (such as DSM criteria) and convergent validity with classic depression inventories, including the Hamilton Rating Scale for Depression (HAM-D) and the Zung Self-Rating Depression Scale (SDS), consistently exceed r = .80. This comprehensive psychometric treatise provides an exhaustive analysis of the scale’s historical development, operational constructs, theoretical foundations, factor analytic structure, diagnostic utility across cognitive spectrums, administrative parameters, and complete authentic item inventory.

Keywords

Geriatric Depression Scale, GDS-30, GDS-15, late-life depression, geriatric psychometrics, affective disorders in aging, psychiatric rating scale, cognitive aging, clinical screening, depressive symptomatology, psychogeriatrics, Yesavage.

Authors

The development and initial validation of the Geriatric Depression Scale were conducted by a multidisciplinary team of psychiatrists, psychologists, and gerontological researchers based at the Veterans Administration Medical Center in Palo Alto, California, and the Stanford University School of Medicine:

• Jerome A. Yesavage, M.D. — Professor of Psychiatry and Behavioral Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine; Director of the Aging Clinical Research Center (ACRC) and Chief of the Psychiatry Service, VA Palo Alto Health Care System, Palo Alto, California, USA.
• T. L. Brink, Ph.D. — Clinical Psychologist, Palo Alto Veterans Affairs Medical Center, Palo Alto, California, and Professor of Psychology and Sociology, Crafton Hills College, Yucaipa, California, USA.
• Terrence L. Rose, Ph.D. — Research Associate, Veterans Administration Medical Center, Palo Alto, California, USA.
• Owen Lum, M.D. — Clinical Fellow in Geriatric Psychiatry, Stanford University School of Medicine and Palo Alto VA Medical Center, California, USA.
• Vicki Huang, M.A. — Statistician and Psychometrician, Aging Clinical Research Center, Palo Alto VA Medical Center, California, USA.
• Adeyemi Adey, M.D. — Clinical Researcher, Veterans Administration Medical Center, Palo Alto, California, USA.
• Von O. Leirer, Ph.D. — Research Psychologist, Aging Clinical Research Center, VA Palo Alto Health Care System, Palo Alto, California, USA.
• J. I. Sheikh, M.D. — (Co-developer of the 15-item short form) Professor of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.

Purpose

The primary clinical and psychometric purpose of the Geriatric Depression Scale is to deliver an empirically validated, reliable, and easily administrable screening instrument calibrated specifically for the diagnostic realities of older adults aged 65 years and older. Prior to the construction of the GDS in the early 1980s, clinicians and researchers relied almost exclusively on instruments calibrated on younger or middle-aged adult psychiatric cohorts, most notably the Beck Depression Inventory (BDI), the Hamilton Rating Scale for Depression (HAM-D), and the Zung Self-Rating Depression Scale (SDS). While these legacy scales exhibited excellent utility in general adult psychiatric practice, their application to geriatric populations was severely compromised by systematic diagnostic confounding.

Traditional depression assessment instruments rely heavily on somatic and neurovegetative criteria, including sleep architecture disruption (insomnia or hypersomnia), appetite and weight fluctuations, generalized physical fatigue, psychomotor retardation, gastrointestinal complaints, and somatic preoccupation. In older adult populations, however, such somatic symptoms occur with high prevalence as secondary manifestations of chronic medical co-morbidities (e.g., congestive heart failure, chronic obstructive pulmonary disease, osteoarthritis, diabetes mellitus), normal age-associated physiological changes, polypharmacy, and neurodegenerative alterations. Consequently, when conventional scales were administered to elderly patients, they produced inflated false-positive rates, erroneously classifying chronically ill but non-depressed geriatric individuals as clinically depressed. Conversely, true late-life depression, which frequently manifests as motivational depletion, apathy, cognitive slowing, loss of vitality, and anhedonia without overt guilt or dramatic affective displays (often termed “depression without sadness” or depressio sine depressione), was frequently under-recognized.

To resolve this psychometric dilemma, Yesavage and colleagues (1982, 1983) purposefully stripped the scale of overt somatic items. The GDS concentrates on the core non-somatic phenomenology of geriatric affective illness: anhedonia, subjective feelings of life emptiness, boredom, social withdrawal, loss of interest in ongoing pursuits, pervasive helplessness, perceived cognitive dysfunction, and generalized hopelessness. The theoretical and practical rationale also dictated the selection of an accessible response format. Likert-type scales featuring multi-point continuous anchors (e.g., 4-point to 7-point scales ranging from “Strongly Disagree” to “Strongly Agree” or subtle frequency ratings) frequently trigger cognitive burden, confusion, and central-tendency response bias in frail elderly respondents experiencing executive slowing, sensory deficits, or mild cognitive impairment. The dichotomous “Yes/No” operationalization was selected precisely to eliminate ambiguity, enhance patient compliance, reduce administration time, and ensure that the instrument could be reliably completed either via self-report or through oral administration by paraprofessional staff, nurses, physicians, and clinical psychologists.

In contemporary clinical and empirical research environments, the GDS serves multiple operational purposes:

• Primary Care and Community Triage: Rapidly identifying community-dwelling older adults who require comprehensive secondary psychiatric evaluation for major depressive episode or persistent depressive disorder.
• Long-Term Care and Skilled Nursing Screening: Providing routine quarterly or annual monitoring of depressive symptoms among institutionalized residents to distinguish institutional adjustment reactions from syndromal mood pathology.
• Geriatric Medical and Inpatient Rehabilitation Triage: Disentangling affective syndromes from somatic illness during post-stroke rehabilitation, orthopedic recovery, or acute medical admissions.
• Epidemiological and Pharmacological Clinical Trials: Offering a standardized, culturally robust dimensional metric for assessing longitudinal change, therapeutic efficacy, and remission trajectory in response to pharmacotherapy, psychotherapy, or neurostimulation modalities.

Psychological Construct

The Geriatric Depression Scale measures a multidimensional psychological construct centered on affective, cognitive, motivational, and existential manifestations of depressive pathology in the aging individual. Rather than viewing late-life depression as an isomorphic analog of early-onset major depression, the construct operationalized by the GDS reflects the specific psychological phenomenology characteristic of the senescence life stage. Analysis of the scale’s 30 items demonstrates coverage across several distinct psychological dimensions:

1. Depressed Mood and Affective Dysphoria

This core dimension evaluates the presence of negative affect, pervasive sadness, and affective instability. Unlike adolescent or young-adult depression inventories that emphasize deep psychological guilt, self-reproach, and dramatic crying spells, the GDS captures affective dysphoria through items that probe chronic emotional despondency, affective resilience, and subjective well-being. Prototypical items assessing this dimension include Item 16 (“Do you often feel downhearted and blue?”), Item 25 (“Do you frequently feel like crying?”), and negatively scored resilience items such as Item 7 (“Are you in good spirits most of the time?”) and Item 9 (“Do you feel happy most of the time?”).

2. Anhedonia and Life Satisfaction

Anhedonia—the diminished capacity to experience pleasure from previously rewarding stimuli—is a central neurobiological and psychological hallmark of geriatric affective disorders. The GDS captures both consummatory and anticipatory anhedonia, alongside broader global evaluations of life satisfaction and vitality. Items operationalizing this dimension include Item 1 (“Are you basically satisfied with your life?”), Item 15 (“Do you think it is wonderful to be alive now?”), Item 19 (“Do you find life very exciting?”), and Item 27 (“Do you enjoy getting up in the morning?”). In older adults, loss of pleasure and perceived life stagnation often represent early indicators of emerging vascular or neurodegenerative depression.

3. Behavioral Disengagement and Apathy

Often overlapping with the clinical syndrome of apathy, behavioral disengagement reflects a critical reduction in goal-directed activities, voluntary socialization, and everyday initiative. Older adults with elevated scores on this dimension show a constricted life space and passivity. This is directly measured by Item 2 (“Have you dropped many of your activities and interests?”), Item 4 (“Do you often get bored?”), Item 12 (“Do you prefer to stay at home, rather than going out and doing new things?”), Item 20 (“Is it hard for you to get started on new projects?”), and Item 28 (“Do you prefer to avoid social gatherings?”).

4. Feelings of Emptiness, Worthlessness, and Hopelessness

Existential despair in late life frequently presents as a sense that one’s useful lifespan has concluded, accompanied by demoralization and negative social comparisons. The GDS directly targets this triad of cognitive-affective distress through Item 3 (“Do you feel that your life is empty?”), Item 17 (“Do you feel pretty worthless the way you are now?”), Item 22 (“Do you feel that your situation is hopeless?”), and Item 23 (“Do you think that most people are better off than you are?”). These cognitive appraisals are clinically salient predictors of passive death wishes and late-life suicidality.

5. Cognitive Complaints and Perceived Mental Decline

Geriatric depression frequently manifests with subjective memory complaints and perceived intellectual slowing—a clinical picture historically termed depressive pseudodementia or the dementia syndrome of depression. The GDS explicitly assesses the patient’s subjective evaluation of their cognitive competence via Item 14 (“Do you feel you have more problems with memory than most?”), Item 26 (“Do you have trouble concentrating?”), Item 29 (“Is it easy for you to make decisions?”), and Item 30 (“Is your mind as clear as it used to be?”). These items isolate the subjective distress surrounding cognitive performance, which often dissipates upon successful resolution of the affective episode.

6. Helplessness and Vulnerability

Perceptions of personal vulnerability, external locus of control, and powerlessness over one’s physiological, economic, or social condition constitute a major facet of late-life mood disruption. This is measured by Item 8 (“Are you afraid that something bad is going to happen to you?”) and Item 10 (“Do you often feel helpless?”). Such items tap into somatic and generalized catastrophic anticipations without asking about physical organ dysfunction directly.

7. Rumination, Anxiety, and Psychomotor Agitation

Although the GDS intentionally omits autonomic somatic items, it captures the psychological tension, intrusive thoughts, and motor restlessness that frequently co-occur with agitated depression in elderly cohorts. This construct is reflected in Item 6 (“Are you bothered by thoughts you can’t get out of your head?”), Item 11 (“Do you often get restless and fidgety?”), Item 13 (“Do you frequently worry about the future?”), Item 18 (“Do you worry a lot about the past?”), and Item 24 (“Do you frequently get upset over little things?”).

Theoretical Framework

The construction and clinical validity of the Geriatric Depression Scale rest upon several converging bodies of psychological and psychiatric theory: Beck’s Cognitive Model of Depression, Seligman’s Learned Helplessness Theory, Erikson’s Stages of Psychosocial Development, and modern neurocognitive theories of vascular and geriatric depression.

From the perspective of Aaron T. Beck’s cognitive theory, depression is maintained by systematic cognitive distortions and the activation of latent negative self-schemas that comprise the “cognitive triad”: pervasive negative evaluations of the self (viewed as deficient, worthless, and inadequate), the world/environment (perceived as defeating, unmanageable, and devoid of gratification), and the future (viewed with absolute hopelessness). In older adults, the cognitive triad frequently becomes activated by age-related transitions, such as widowhood, retirement, decline in socioeconomic status, and physical functional limitations. Items across the GDS directly operationalize this negative cognitive triad by probing self-worth (Item 17: “Do you feel pretty worthless the way you are now?”), environmental appraisals (Item 3: “Do you feel that your life is empty?”), and prospective expectations (Item 22: “Do you feel that your situation is hopeless?”). By prioritizing these systematic cognitive appraisals over vegetative manifestations, the GDS aligns directly with Beck’s premise that cognitive distortions are primary drivers of depressive dysphoria.

Seligman’s learned helplessness paradigm, alongside its reformulated attributional framework (Abramson, Seligman, & Teasdale), provides a critical theoretical foundation for the GDS’s focus on perceived helplessness and passivity. In late life, individuals are repeatedly confronted with uncontrollable and irreversible adverse life events, including the loss of peers, institutionalization, physical sensory degradation, and institutional dependency. When an older adult attributes these negative outcomes to internal, stable, and global factors (e.g., “I am old and broken; nothing can improve my life”), generalized helplessness ensues. This psychological state is marked by behavioral amotivation, cognitive passivity, and emotional resignation. The GDS captures this construct through Item 10 (“Do you often feel helpless?”) and Item 8 (“Are you afraid that something bad is going to happen to you?”), reflecting the passive dread and surrender characteristic of learned helplessness.

Developmentally, the GDS intersects with Erik Erikson’s eighth psychosocial stage: Ego Integrity versus Despair. In Erikson’s developmental framework, the central developmental crisis of late adulthood requires synthesizing one’s past life into a meaningful whole, accepting personal triumphs and limitations, and coming to terms with mortality. Achieving ego integrity yields wisdom and peaceful acceptance. Failure to resolve this crisis precipitates existential despair, marked by bitter regret over missed opportunities, acute fear of death, disgust with oneself, and pervasive despondency. Several items in the GDS directly evaluate the psychological products of this unresolved developmental crisis, notably Item 18 (“Do you worry a lot about the past?”), Item 23 (“Do you think that most people are better off than you are?”), and Item 15 (“Do you think it is wonderful to be alive now?”).

Finally, modern neurobiological models of late-life depression—specifically George Alexopoulos’s hypothesis of “Vascular Depression” and “Executive Dysfunction Depression”—illuminate why the GDS’s emphasis on apathy, cognitive slowness, and loss of initiation is so psychometrically powerful. Subcortical ischemic changes (e.g., deep white matter hyperintensities in frontostriatal pathways) disrupt dorsal and ventral executive-limbic circuits, leading to a phenotypic presentation characterized by psychomotor slowing, apathy, executive dysfunction, and diminished affective reactivity without severe guilt. The GDS’s items measuring executive slowing (Item 20, Item 26, Item 29) directly reflect this neurobiological vulnerability, cementing the scale’s alignment with contemporary neuropsychiatric frameworks.

Validity

The Geriatric Depression Scale has been subject to extensive empirical validation across diverse clinical, institutional, and cross-cultural cohorts over the past four decades. Psychometric evaluations consistently confirm robust construct, convergent, discriminant, and criterion-related validity.

Criterion-Related and Diagnostic Validity

In the seminal validation study conducted by Yesavage, Brink, Rose, et al. (1983), the 30-item GDS was evaluated in an elderly cohort categorized into non-depressed normal control subjects, mildly depressed individuals, and severely depressed inpatients diagnosed according to Research Diagnostic Criteria (RDC). The mean total GDS scores differed significantly across groups: normal control subjects exhibited a mean score of 5.75 (SD = 4.34), mildly depressed patients scored 14.93 (SD = 5.25), and severely depressed patients scored 22.88 (SD = 4.79; p < .001). Subsequent studies utilizing structured clinical interviews based on DSM-III, DSM-III-R, DSM-IV, and DSM-5 criteria confirmed the scale’s high diagnostic accuracy for detecting major depressive disorder.

Receiver Operating Characteristic (ROC) analyses demonstrate optimal cut-off performance for the GDS-30:

• Cut-off score of 10/11: Yields a clinical sensitivity of 84% to 88% and a specificity of 95% for distinguishing clinically depressed geriatric patients from non-depressed controls. A threshold of 11 or higher serves as the standard screening benchmark indicating probable depressive illness.
• Cut-off score of 13/14: Raises specificity to 98%–100% while maintaining sensitivity at approximately 80%, providing an ideal threshold when minimizing false positives is paramount (e.g., clinical trial inclusion criteria).

For the 15-item short form (Sheikh & Yesavage, 1986), a cut-off score of 5 or higher exhibits a sensitivity ranging from 80% to 92% and a specificity of 81% to 91% across general primary care and community-dwelling elderly cohorts.

Convergent and Discriminant Validity

Convergent validity is firmly established through high correlations with established clinician-rated and self-report depression scales. Yesavage et al. (1983) documented correlations of r = .83 between the GDS and the clinician-administered Hamilton Rating Scale for Depression (HAM-D), and r = .84 with the self-rated Zung Self-Rating Depression Scale (SDS). Importantly, despite high overall convergence, correlations between the GDS and the HAM-D somatic sub-indices are systematically lower than correlations with the HAM-D cognitive-affective sub-indices, confirming that the GDS successfully divorces depressive screening from somatic illness.

Discriminant validity analyses indicate that the GDS reliably distinguishes depression from generalized cognitive decline in the early stages of dementia, although its diagnostic fidelity degrades in moderate-to-severe dementia. Watson, Zimmerman, Cohen, and Dominik (2009) demonstrated that while the GDS exhibits excellent discriminative power for determining symptom severity and the presence versus absence of syndromal depression, it does not discriminate between primary major depression and secondary adjustment reactions or mood disorders secondary to general medical conditions without additional diagnostic inquiry. Psychometric studies by Marc, Raue, and Bruce (2008), Rait et al. (1999), and Harralson et al. (2002) demonstrate that validity coefficients remain robust across variations in age, educational attainment, sex, racial groups, and cultural backgrounds.

Reliability

The Geriatric Depression Scale exhibits exemplary reliability across internal consistency, split-half, and test-retest metrics in both community and clinical geriatric populations.

Internal Consistency

In the original validation study by Yesavage et al. (1983), the 30-item scale demonstrated a Cronbach’s alpha coefficient of .94, reflecting high internal consistency without excessive item redundancy. Split-half reliability, calculated via the Spearman-Brown prophecy formula, yielded an identical coefficient of .94. In subsequent independent replications across international cohorts—including studies in the United Kingdom, Scandinavia, East Asia, and Latin America—internal consistency estimates for the GDS-30 have consistently clustered between .89 and .95.

The 15-item short form (GDS-15) maintains acceptable to excellent internal consistency, with published alpha coefficients typically ranging from .80 to .90 across various geriatric samples (e.g., Malakouti et al., 2006). Item-total correlation analyses for the 30-item form reveal that 28 of the 30 items exhibit corrected item-total correlations exceeding .35, with the vast majority falling between .45 and .72, indicating strong cohesive alignment with the underlying latent depressive construct.

Test-Retest Stability

Because depression is an episodic affective state that responds to environmental shifts and therapeutic interventions, test-retest reliability must be evaluated over intervals long enough to avoid immediate recall bias, yet brief enough to precede spontaneous clinical recovery or disease trajectory shifts:

• One-Week Interval: Yesavage et al. (1983) reported a test-retest reliability coefficient of r = .85 (p < .001) in stable older individuals evaluated one week apart.
• One-Month Interval: In a landmark methodological study of institutionalized and congregate housing residents, Parmelee, Lawton, and Katz (1989) demonstrated a test-retest coefficient of r = .85 (p < .001) across a 30-day testing window.

These findings substantiate that in the absence of targeted psychiatric interventions, the GDS captures stable individual differences in depressive mood rather than transient daily emotional fluctuations.

Inter-Rater and Administration Modality Reliability

Although conceptualized as a self-report instrument, clinical realities often require the GDS to be administered by an interviewer. Comparative studies show that oral presentation by a clinician or trained researcher yields an inter-rater concordance correlation exceeding r = .90 when compared to self-completion. Furthermore, Burke, Roccaforte, Wengel, Conley, and Potter (1995) established that telephone administration of the GDS preserves both internal consistency and rank-order reliability (r > .85), supporting its integration into remote telehealth protocols and community longitudinal surveys.

Factor Analysis

Although the GDS was engineered to deliver a unidimensional composite index of depressive severity, four decades of exploratory factor analyses (EFA) and confirmatory factor analyses (CFA) have uncovered a robust multidimensional latent architecture that reflects the clinical heterogeneity of late-life depression.

Exploratory Factor Analyses (EFA)

Initial exploratory factor investigations of the GDS-30 by Yesavage and colleagues, followed by extensive structural analyses (e.g., Sheikh & Yesavage, 1986; Parmelee et al., 1989; Adams, 2001), generally identified between four and six underlying latent factors accounting for 45% to 60% of the total variance. The classic 5-factor model represents the most consistently replicated extraction:

• Factor 1: Dysphoric Mood / Depressive Affect: Explaining the largest proportion of total variance (20%–28%), this factor captures overt depressive affect, sadness, and negative cognitions. Core loading items include Item 16 (“downhearted and blue”), Item 25 (“feel like crying”), Item 6 (“thoughts you can’t get out of your head”), and reverse-coded Item 7 (“in good spirits”) and Item 9 (“happy most of the time”), with factor loadings typically ranging between .58 and .76.
• Factor 2: Apathy, Anhedonia, and Loss of Energy: Characterized by behavioral withdrawal and motivational deficit, this factor exhibits high loadings on Item 2 (“dropped activities”), Item 4 (“get bored”), Item 19 (“find life exciting”), Item 20 (“hard to get started”), and Item 21 (“feel full of energy”), with loadings from .50 to .72.
• Factor 3: Positive Affect / Life Satisfaction: Capturing the presence or absence of psychological flourishing and zest for life, this factor features high loadings on Item 1 (“satisfied with life”), Item 15 (“wonderful to be alive”), Item 27 (“enjoy getting up”), and Item 5 (“hopeful about the future”).
• Factor 4: Cognitive Concern / Intellectual Efficiency: Comprising subjective perceptions of neurocognitive failure, this factor includes Item 14 (“memory problems”), Item 26 (“trouble concentrating”), Item 29 (“decision making”), and Item 30 (“mind clear”), with factor loadings ranging from .44 to .68.
• Factor 5: Agitation, Worry, and Helplessness: Reflecting emotional lability and dread, this factor loads heavily on Item 8 (“afraid bad will happen”), Item 10 (“feel helpless”), Item 11 (“restless and fidgety”), Item 13 (“worry about future”), Item 18 (“worry about past”), and Item 24 (“upset over little things”).

Confirmatory Factor Analyses (CFA) and Model Fit

Confirmatory factor analytic investigations have evaluated various competing models (unidimensional, hierarchical, 3-factor, 5-factor, and bi-factor models). In structural equation modeling studies across diverse elderly samples, a single general second-order factor (“General Depression”) driving three to five correlated first-order subdomains has consistently shown the most acceptable fit indices:

• Comparative Fit Index (CFI): .92 to .95
• Tucker-Lewis Index (TLI): .91 to .94
• Root Mean Square Error of Approximation (RMSEA): .042 to .058 (with 90% confidence intervals spanning .035–.062)
• Standardized Root Mean Square Residual (SRMR): .048 to .054

These CFA parameters substantiate the dual clinical utility of the GDS: the total composite score functions as an empirically defensible omnibus index of late-life depression severity, while individual factor subscale scores offer granular phenotypic profiles that can guide personalized pharmacotherapeutic or behavioral interventions.

Instrument / Measurement Tool

The Geriatric Depression Scale is structured as follows:

• Instrument Name: Geriatric Depression Scale (GDS); original version often designated as Geriatric Depression Scale – Long Form (GDS-LF) or GDS-30.
• Primary Developer: Jerome A. Yesavage, M.D., and colleagues (1982, 1983).
• Target Population: Older adults (typically aged 65 years and older) across community, outpatient, acute inpatient, and long-term care residential environments.
• Instrument Type: Self-administered psychometric screening questionnaire (can also be clinician- or observer-administered).
• Administration Format: Paper-and-pencil questionnaire, oral structured interview, telephone interview, or computerized/digital assessment.
• Completion Time: 8 to 15 minutes for the 30-item long form; 3 to 5 minutes for the 15-item short form.
• Item Count: 30 items on the comprehensive long form; 15 items on the standard short form (Sheikh & Yesavage, 1986).
• Response Scale: Dichotomous forced-choice format: Yes / No.
• Timeframe: Past week (“Choose the best answer for how you have felt over the past week”).
• Scoring Key and Method:
  • Each item is scored either 0 (indicating the absence of a depressive symptom) or 1 (indicating the presence of a depressive symptom).
  • Symptom Present = “Yes” (1 point each; 20 items): Items 2, 3, 4, 6, 8, 10, 11, 12, 13, 14, 16, 17, 18, 20, 22, 23, 24, 25, 26, 28.
  • Symptom Present = “No” (reverse-scored, 1 point each; 10 items): Items 1, 5, 7, 9, 11*, 15, 19, 21, 27, 29, 30. (Note: On the standard GDS-30, Item 11 is keyed ‘Yes’ for restlessness; the 10 reverse-keyed items indicating depression when answered ‘No’ are Items 1, 5, 7, 9, 15, 19, 21, 27, 29, and 30).
  • Total score is the direct sum of all keyed points, yielding an overall potential range of 0 to 30.
• Diagnostic Severity Cut-Off Score Benchmarks (GDS-30):
  • 0 – 9 points: Normal / Non-depressed (no clinically significant depressive symptomatology).
  • 10 – 19 points: Mild Depression (suggestive of mild affective disturbance; warrants further comprehensive clinical interview).
  • 20 – 30 points: Severe Depression (indicative of moderate-to-severe depressive illness; requires urgent psychiatric and diagnostic intervention).
  • Alternate dichotomous screening cutoff: A score of 11 or greater serves as the standard cutoff for discriminating presence versus absence of clinical depression.
• Diagnostic Cut-Off Score Benchmarks for Short Form (GDS-15):
  • 0 – 4 points: Normal / Non-depressed.
  • 5 – 8 points: Mild Depression.
  • 9 – 11 points: Moderate Depression.
  • 12 – 15 points: Severe Depression.
  • Standard screening cutoff: A score of 5 or greater indicates probable depression.

Permissions & Fee and Test Year

The Geriatric Depression Scale was formally published in its definitive 30-item validation form in 1983 (preliminary developmental work published in late 1982) by Jerome A. Yesavage, T. L. Brink, and colleagues. The 15-item short form was subsequently validated and published in 1986 by J. I. Sheikh and Jerome A. Yesavage.

Licensing and Availability: The Geriatric Depression Scale (in both its 30-item and 15-item versions) is placed squarely in the public domain. The original developers intentionally refrained from copyrighting the instrument for commercial profit, explicitly dedicating the scale to public clinical and academic use to advance geriatric mental health care worldwide. Consequently, no licensing fees, copyright purchase costs, or formal royalty permissions are required for clinical practice, institutional assessment, or non-commercial academic research. Researchers and clinicians are free to reproduce, translate, digitize, and utilize the instrument, provided that standard scholarly attribution is accorded to the primary developers (Yesavage et al., 1982–1983; Sheikh & Yesavage, 1986). Official documentation, scoring templates, and validated international linguistic translations are curated by the Aging Clinical Research Center at Stanford University School of Medicine.

References

Aikman, G. G., & Oehlert, M. E. (2001). Geriatric Depression Scale: Long form versus short form. Clinical Gerontologist, 22(3–4), 63–70. https://doi.org/10.1300/J018v22n03_06

Brink, T. L., Yesavage, J. A., Lum, O., Heersema, P. H., Adey, M., & Rose, T. L. (1982). Screening tests for geriatric depression. Clinical Gerontologist, 1(1), 37–43. https://doi.org/10.1300/J018v01n01_06

Burke, W. J., Roccaforte, W. H., Wengel, S. P., Conley, D. M., & Potter, J. F. (1995). The reliability and validity of the Geriatric Depression Scale administered by telephone. Journal of the American Geriatrics Society, 43(6), 674–679. https://doi.org/10.1111/j.1532-5415.1995.tb07198.x

Harralson, T. L., Ten Have, T., Bogner, H. R., Morales, K. H., & Gallo, J. J. (2002). Detecting depression in older primary care patients: The Geriatric Depression Scale and the Center for Epidemiologic Studies-Depression Scale. Journal of the American Geriatrics Society, 50(12), 2097–2098. https://doi.org/10.1046/j.1532-5415.2002.50630.x

Holroyd, S., & Clayton, A. H. (2000). Measuring depression in the elderly: Which scale is best? Primary Care Companion to the Journal of Clinical Psychiatry, 2(3), 89–93. https://doi.org/10.4088/pcc.v02n0303

Lesher, E. L., & Berryhill, J. S. (1994). Validation of the Geriatric Depression Scale-Short Form among inpatients. Journal of Clinical Psychology, 50(2), 256–260. https://doi.org/10.1002/gps.1533

Marc, L. G., Raue, P. J., & Bruce, M. L. (2008). Screening performance of the 15-item Geriatric Depression Scale in racially/ethnically diverse older adults. Journal of Affective Disorders, 107(1–3), 243–247. https://doi.org/10.1016/j.jad.2007.08.016

McGivney, C. A., Mulvihill, M., & Taylor, B. (1994). Validating the GDS depression scale in the mildly demented elderly. The Gerontologist, 34(1), 127–130. https://doi.org/10.1093/geront/34.1.127

Parmelee, P. A., Lawton, M. P., & Katz, I. R. (1989). Psychometric properties of the Geriatric Depression Scale among the institutionalized aged. Psychological Assessment: A Journal of Consulting and Clinical Psychology, 1(4), 331–338. https://doi.org/10.1037/1040-3590.1.4.331

Rait, G., Fletcher, A., & Smeeth, L. (1999). Screening for depression in elderly people: Which scale should be used? The British Journal of General Practice, 49(448), 874–879. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1313554/

Sansoni, J., Vellone, E., & Piras, G. (2007). Depressive symptoms in older adults: A psychometric comparison of screening instruments. International Journal of Nursing Studies, 44(8), 1432–1440. https://doi.org/10.1016/j.ijnurstu.2006.07.020

Sheikh, J. I., & Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontologist, 5(1–2), 165–173. https://doi.org/10.1300/J018v05n01_09

Watson, L. C., Zimmerman, S., Cohen, L. W., & Dominik, R. (2009). Practical depression screening in residential care/assisted living: Comparison of five instruments. Journal of the American Geriatrics Society, 57(10), 1821–1828. https://doi.org/10.1111/j.1532-5415.2009.02450.x

Yesavage, J. A. (1988). Geriatric Depression Scale. Psychopharmacology Bulletin, 24(4), 709–711. https://pubmed.ncbi.nlm.nih.gov/3249773/

Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1983). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17(1), 37–49. https://doi.org/10.1016/0022-3956(82)90033-4

Items of the Scale